Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Forman

Showing results (321-330 of 504) with videos related to

Pageof 51
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 25, 2019
Association between Clonal Hematopoiesis and Late Nonrelapse Mortality after Autologous Hematopoietic Cell TransplantationThomas P Slavin, Jennifer Berano Teh, Jeffrey N Weitzel, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 8, 2020
Toxicities Associated With Metformin/Ritonavir Combination Treatment in Relapsed/Refractory Multiple MyelomaNitya Nathwani, Joycelynne Palmer, Timothy W Synold, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2018
Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703)Eileen P Smith, Hongli Li, Jonathan W Friedberg, et al.
Blood|October 4, 2003
Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioningWolfgang A Bethge, Ute Hegenbart, Monic J Stuart, et al.
Blood|September 14, 2013
T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemiaArmen Mardiros, Cedric Dos Santos, Tinisha McDonald, et al.
American Journal of Hematology|November 19, 2016
Philadelphia chromosome as a recurrent event among therapy-related acute leukemiaIbrahim Aldoss, Tracey Stiller, Joo Song, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2007
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphomaAndrew R Rezvani, Barry Storer, Michael Maris, et al.
JAMA Dermatology|December 18, 2024
Incidence of and Risk Factors for Cutaneous Malignant Neoplasms After Blood or Marrow TransplantKristy K Broman, Qingrui Meng, Anna Holmqvist, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 2, 2024
A platform to deliver single and bi-specific Cas9/guide RNA to perturb genes in vitro and in vivoYi-Jia Li, Sheng-Hsuan Chien, Rui Huang, et al.
Blood Advances|December 10, 2019
Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agentsIbrahim Aldoss, Sanjeet Dadwal, Jianying Zhang, et al.
Pageof 51

Showing results (321-330 of 504) with videos related to

Sort By:
Pageof 51
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 25, 2019
Association between Clonal Hematopoiesis and Late Nonrelapse Mortality after Autologous Hematopoietic Cell TransplantationThomas P Slavin, Jennifer Berano Teh, Jeffrey N Weitzel, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 8, 2020
Toxicities Associated With Metformin/Ritonavir Combination Treatment in Relapsed/Refractory Multiple MyelomaNitya Nathwani, Joycelynne Palmer, Timothy W Synold, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2018
Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703)Eileen P Smith, Hongli Li, Jonathan W Friedberg, et al.
Blood|October 4, 2003
Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioningWolfgang A Bethge, Ute Hegenbart, Monic J Stuart, et al.
Blood|September 14, 2013
T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemiaArmen Mardiros, Cedric Dos Santos, Tinisha McDonald, et al.
American Journal of Hematology|November 19, 2016
Philadelphia chromosome as a recurrent event among therapy-related acute leukemiaIbrahim Aldoss, Tracey Stiller, Joo Song, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2007
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphomaAndrew R Rezvani, Barry Storer, Michael Maris, et al.
JAMA Dermatology|December 18, 2024
Incidence of and Risk Factors for Cutaneous Malignant Neoplasms After Blood or Marrow TransplantKristy K Broman, Qingrui Meng, Anna Holmqvist, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 2, 2024
A platform to deliver single and bi-specific Cas9/guide RNA to perturb genes in vitro and in vivoYi-Jia Li, Sheng-Hsuan Chien, Rui Huang, et al.
Blood Advances|December 10, 2019
Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agentsIbrahim Aldoss, Sanjeet Dadwal, Jianying Zhang, et al.
Pageof 51